Institute for Clinical and Economic Review to Assess Evidence on Supervised Injection Facilities and Digital Apps for Opioid Use Disorder
February 22, 2020
February 22, 2020
BOSTON, Massachusetts, Feb. 22 -- The Institute for Clinical and Economic Review issued the following announcement on Feb. 21:
The Institute for Clinical and Economic Review (ICER) announced plans to assess the comparative clinical effectiveness and economic value of two non-drug topics: supervised injection facilities (SIFs) and digital apps for opioid use disorder. Along with past ICER assessments of related topics such as abuse-deterrent opioid formulations, medication-assisted t . . .
The Institute for Clinical and Economic Review (ICER) announced plans to assess the comparative clinical effectiveness and economic value of two non-drug topics: supervised injection facilities (SIFs) and digital apps for opioid use disorder. Along with past ICER assessments of related topics such as abuse-deterrent opioid formulations, medication-assisted t . . .